For node-positive patients, Figure 3B points out that TNBC breast carcinoma patients tend to have the worst 5-year overall survival, by log-rank analysis, and that ER-positive and/or PgR-positive and HER2-negative patients have the best 5-year overall survival (p < 0.0001). This evidence concerns the gene ESR1 and breast carcinoma.